Continuous dosing regimen with abt-751

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/24 (2006.01) A61K 31/635 (2006.01)

Patent

CA 2526385

Compositions comprising the cancer drug N-2(2-((4-hydroxyphenyl) amino)pyrid-3- yl)-4-methoxybenzenesulfonamide (ABT-751), continuous oral dosing schedule with said drug which binds to the colchicine site of tubulin .szlig.-subunits, and methods of treating diseases using continuous dosing schedules are disclosed.

L'invention se rapporte à des compositions comprenant un ou plusieurs médicaments anticancéreux, à un schéma posologique d'administration en continu, par voie orale, de médicaments qui se fixent sur le site colchicine des sous-unités .szlig. de la tubuline, ainsi qu'à des procédés permettant de traiter des maladies au moyen des schémas posologiques d'administration en continu selon l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Continuous dosing regimen with abt-751 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Continuous dosing regimen with abt-751, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Continuous dosing regimen with abt-751 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1344200

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.